Annual ROE
3.06%
+1.58%+106.76%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual return on equity is currently 3.06%, with the most recent change of +1.58% (+106.76%) on 31 March 2024. During the last 3 years, it has risen by +23.38% (+115.06%).TARO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
3.06%
+0.43%+16.35%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly return on equity is currently 3.06%, with the most recent change of +0.43% (+16.35%) on 31 March 2024. Over the past year, it has increased by +1.16% (+61.05%).TARO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +106.8% | +61.0% |
3 y3 years | +115.1% | +580.0% |
5 y5 years | -77.6% | -77.5% |
TARO ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -93.8% | -94.1% |
Taro Pharmaceutical Industries ROE History
Date | Annual | Quarterly |
---|---|---|
Mar 2024 | 3.06%(+106.8%) | 3.06%(+16.3%) |
Dec 2023 | - | 2.63%(+38.4%) |
Sept 2023 | - | 1.90%(+53.2%) |
June 2023 | - | 1.24%(-16.8%) |
Mar 2023 | 1.48%(-56.7%) | 1.49%(-44.6%) |
Dec 2022 | - | 2.69%(-29.6%) |
Sept 2022 | - | 3.82%(-29.1%) |
June 2022 | - | 5.39%(+56.2%) |
Mar 2022 | 3.42%(-116.8%) | 3.45%(+5650.0%) |
Dec 2021 | - | 0.06%(-86.7%) |
Sept 2021 | - | 0.45%(-74.1%) |
June 2021 | - | 1.74%(-108.1%) |
Mar 2021 | -20.32%(-267.2%) | -21.60%(+33.1%) |
Dec 2020 | - | -16.23%(+16.3%) |
Sept 2020 | - | -13.95%(+7.1%) |
June 2020 | - | -13.03%(-207.7%) |
Mar 2020 | 12.15%(-11.1%) | 12.10%(-4.3%) |
Dec 2019 | - | 12.64%(-6.9%) |
Sept 2019 | - | 13.57%(+0.1%) |
June 2019 | - | 13.55%(+1.9%) |
Mar 2019 | 13.67%(+38.6%) | 13.30%(-6.5%) |
Dec 2018 | - | 14.22%(+36.6%) |
Sept 2018 | - | 10.41%(+2.7%) |
June 2018 | - | 10.14%(+4.1%) |
Mar 2018 | 9.86%(-56.7%) | 9.74%(-0.3%) |
Dec 2017 | - | 9.77%(-38.7%) |
Sept 2017 | - | 15.93%(-20.1%) |
June 2017 | - | 19.93%(-13.9%) |
Mar 2017 | 22.76%(-29.4%) | 23.16%(-9.4%) |
Dec 2016 | - | 25.56%(-12.8%) |
Sept 2016 | - | 29.32%(-5.9%) |
June 2016 | - | 31.17%(-4.6%) |
Mar 2016 | 32.25%(-18.8%) | 32.68%(-13.4%) |
Dec 2015 | - | 37.74%(+0.6%) |
Sept 2015 | - | 37.51%(-9.2%) |
June 2015 | - | 41.30%(+3.2%) |
Mar 2015 | 39.73%(+5.4%) | 40.03%(+6.0%) |
Dec 2014 | - | 37.77%(+1.5%) |
Sept 2014 | - | 37.23%(+7.8%) |
June 2014 | - | 34.53%(-7.3%) |
Mar 2014 | 37.71%(+7.2%) | 37.23%(+8.6%) |
Dec 2013 | - | 34.27%(+4.7%) |
Sept 2013 | - | 32.72%(+2.9%) |
June 2013 | - | 31.80%(-9.0%) |
Mar 2013 | 35.17%(+344.6%) | 34.95%(-7.7%) |
Dec 2012 | - | 37.88%(+0.1%) |
Sept 2012 | - | 37.85%(-7.1%) |
June 2012 | - | 40.74%(+2.8%) |
Mar 2012 | 7.91%(-79.3%) | 39.63%(+1.5%) |
Dec 2011 | 38.23%(+102.9%) | 39.06%(+17.9%) |
Sept 2011 | - | 33.12%(+25.0%) |
June 2011 | - | 26.50%(+13.7%) |
Mar 2011 | - | 23.31%(+13.6%) |
Dec 2010 | 18.84%(-62.0%) | 20.52%(-57.4%) |
Sept 2010 | - | 48.19%(-0.6%) |
June 2010 | - | 48.49%(+6.2%) |
Mar 2010 | - | 45.64%(-12.1%) |
Dec 2009 | 49.58%(+157.8%) | 51.91%(+240.8%) |
Sept 2009 | - | 15.23%(-17.5%) |
June 2009 | - | 18.46%(+17.1%) |
Mar 2009 | - | 15.76%(+278.8%) |
Dec 2008 | 19.23%(-43.2%) | 4.16%(-19.7%) |
Sept 2008 | - | 5.18%(+1338.9%) |
Dec 2007 | 33.83%(-136.4%) | - |
Dec 2006 | -92.98%(<-9900.0%) | - |
Dec 2005 | 0.03% | 0.36%(-92.7%) |
Sept 2005 | - | 4.95%(-10.8%) |
June 2005 | - | 5.55%(+302.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2005 | - | 1.38%(-55.5%) |
Dec 2004 | 3.09%(-84.4%) | 3.10%(-53.0%) |
Sept 2004 | - | 6.59%(-35.8%) |
June 2004 | - | 10.26%(-42.8%) |
Mar 2004 | - | 17.95%(-9.9%) |
Dec 2003 | 19.75%(+8.5%) | 19.92%(-0.4%) |
Sept 2003 | - | 20.00%(+1.7%) |
June 2003 | - | 19.66%(+3.3%) |
Mar 2003 | - | 19.03%(+3.3%) |
Dec 2002 | 18.21%(-5.6%) | 18.42%(-10.6%) |
Sept 2002 | - | 20.60%(-9.8%) |
June 2002 | - | 22.85%(-13.5%) |
Mar 2002 | - | 26.41%(-10.4%) |
Dec 2001 | 19.29%(-12.4%) | 29.46%(-19.2%) |
Sept 2001 | - | 36.46%(+18.5%) |
June 2001 | - | 30.76%(+25.4%) |
Mar 2001 | - | 24.53%(+9.5%) |
Dec 2000 | 22.02%(+38.3%) | 22.40%(+12.2%) |
Sept 2000 | - | 19.96%(+7.0%) |
June 2000 | - | 18.65%(+4.0%) |
Mar 2000 | - | 17.93%(+6.3%) |
Dec 1999 | 15.92%(+94.9%) | 16.87%(+1.9%) |
Sept 1999 | - | 16.56%(+20.3%) |
June 1999 | - | 13.77%(+29.8%) |
Mar 1999 | - | 10.61%(+27.5%) |
Dec 1998 | 8.17%(+57.1%) | 8.32%(+75.2%) |
Sept 1998 | - | 4.75%(-7.0%) |
June 1998 | - | 5.11%(-7.6%) |
Mar 1998 | - | 5.53%(-0.7%) |
Dec 1997 | 5.20%(-40.3%) | 5.57%(-25.9%) |
Sept 1997 | - | 7.52%(+3.2%) |
June 1997 | - | 7.29%(-11.2%) |
Mar 1997 | - | 8.21%(-6.3%) |
Dec 1996 | 8.71%(+0.1%) | 8.76%(+32.5%) |
Sept 1996 | - | 6.61%(+79.1%) |
June 1996 | - | 3.69%(-40.5%) |
Mar 1996 | - | 6.20%(-25.3%) |
Dec 1995 | 8.70%(-49.5%) | 8.30%(-39.7%) |
Sept 1995 | - | 13.76%(-18.9%) |
June 1995 | - | 16.97%(+5.7%) |
Mar 1995 | - | 16.06%(-30.0%) |
Dec 1994 | 17.22%(+1112.7%) | 22.95%(+49.6%) |
Sept 1994 | - | 15.34%(+42.0%) |
June 1994 | - | 10.80%(+111.4%) |
Mar 1994 | - | 5.11%(+348.2%) |
Dec 1993 | 1.42%(-87.5%) | 1.14%(-112.7%) |
Sept 1993 | - | -9.00%(+361.5%) |
June 1993 | - | -1.95%(-199.0%) |
Mar 1993 | - | 1.97%(-79.0%) |
Dec 1992 | 11.39%(-48.7%) | 9.39%(-46.7%) |
Sept 1992 | - | 17.61%(-15.7%) |
June 1992 | - | 20.89%(+32.3%) |
Mar 1992 | - | 15.79%(-29.1%) |
Dec 1991 | 22.22%(-322.2%) | 22.28%(-2.5%) |
Sept 1991 | - | 22.86%(+189.7%) |
June 1991 | - | 7.89%(-66.9%) |
Mar 1991 | - | 23.81%(-320.3%) |
Dec 1990 | -10.00%(-10.0%) | -10.81%(-47.3%) |
Sept 1990 | - | -20.51%(0.0%) |
June 1990 | - | -20.51%(-20.0%) |
Mar 1990 | - | -25.64%(+169.3%) |
Dec 1989 | -11.11%(-266.6%) | -9.52%(-242.7%) |
Sept 1989 | - | 6.67%(0.0%) |
June 1989 | - | 6.67%(-50.0%) |
Mar 1989 | - | 13.33%(+99.9%) |
Dec 1988 | 6.67% | 6.67%(0.0%) |
Sept 1988 | - | 6.67%(0.0%) |
June 1988 | - | 6.67% |
FAQ
- What is Taro Pharmaceutical Industries annual return on equity?
- What is the all time high annual ROE for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual ROE year-on-year change?
- What is Taro Pharmaceutical Industries quarterly return on equity?
- What is the all time high quarterly ROE for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly ROE year-on-year change?
What is Taro Pharmaceutical Industries annual return on equity?
The current annual ROE of TARO is 3.06%
What is the all time high annual ROE for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual return on equity is 49.58%
What is Taro Pharmaceutical Industries annual ROE year-on-year change?
Over the past year, TARO annual return on equity has changed by +1.58% (+106.76%)
What is Taro Pharmaceutical Industries quarterly return on equity?
The current quarterly ROE of TARO is 3.06%
What is the all time high quarterly ROE for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly return on equity is 51.91%
What is Taro Pharmaceutical Industries quarterly ROE year-on-year change?
Over the past year, TARO quarterly return on equity has changed by +1.16% (+61.05%)